You need a prescription to get semaglutide legally in the U.S. 1, 2. Options may include brand-name Wegovy, Ozempic, or Rybelsus, or compounded semaglutide prescribed by a licensed clinician and prepared by a state-licensed 503A pharmacy; compounded semaglutide is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality 4. Chia offers clinician-reviewed compounded semaglutide injection starting at $249/month for eligible patients.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you buy semaglutide without a prescription?
Semaglutide is a prescription medication in the U.S., so legitimate access requires clinician review before treatment. That applies to FDA-approved brand-name products and to compounded semaglutide prepared by a licensed compounding pharmacy.
Why legitimate semaglutide access requires clinician review
Semaglutide can affect blood sugar, digestion, appetite, and hydration. FDA labels for semaglutide products describe risks such as nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis warnings, kidney injury related to dehydration, low blood sugar risk when used with insulin or sulfonylureas, and a boxed warning about thyroid C-cell tumors based on rodent data 1, 2, 3.
That is why a clinician needs to review your history before any prescription. The review may include your weight-related goals, type 2 diabetes history, pregnancy plans, history of pancreatitis or gallbladder disease, family or personal history of medullary thyroid carcinoma or MEN2, current medications, and prior side effects with GLP-1 medicines 1, 2.
Why patients should avoid non-prescription or research-use products
Avoid websites that sell “semaglutide peptide,” “research use only” vials, or no-prescription products for self-treatment. FDA has warned that unapproved GLP-1 products may raise quality, dosing, and safety concerns, and that some products marketed as semaglutide may use salt forms that are not the same active ingredient as the FDA-approved base form 5.
A safer access path has three parts: a licensed clinician, a prescription when appropriate, and a state-licensed pharmacy. If you are still comparing online options, our guide to buying GLP-1 medication online explains what to check before you pay.
What semaglutide options are available?
Semaglutide is available through several prescription pathways: brand-name products with FDA-approved labels and compounded semaglutide prepared for an individual patient when prescribed. These options are related by active ingredient, but they are not identical products.
Brand-name semaglutide: Wegovy, Ozempic, and Rybelsus
Wegovy is semaglutide, a GLP-1 receptor agonist, approved for chronic weight management in certain adults and adolescents and for reducing certain cardiovascular risks in adults with established cardiovascular disease and obesity or overweight 1. Ozempic is semaglutide injection approved for adults with type 2 diabetes and for reducing certain cardiovascular and kidney-related risks in that population 2. Rybelsus is oral semaglutide approved for adults with type 2 diabetes 3.
In STEP 1, a randomized trial of semaglutide 2.4 mg once weekly plus lifestyle intervention in adults with overweight or obesity without diabetes, the active ingredient as studied led to greater average weight loss than placebo over 68 weeks; individual results varied, and gastrointestinal side effects were common 6. These trial results do not establish outcomes for compounded formulations, which are not FDA-approved.
Compounded semaglutide via a 503A pharmacy
Compounded semaglutide is prepared by a compounding pharmacy for a patient-specific prescription. Under section 503A of the Federal Food, Drug, and Cosmetic Act, eligible compounded drugs can be made by licensed pharmacies when legal requirements are met, but they are not FDA-approved and do not go through FDA premarket review for safety, effectiveness, or quality 4.
At Chia, our providers evaluate patients online and, where clinically appropriate, prescribe compounded semaglutide injection through state-licensed U.S. 503A pharmacies. We do not describe compounded semaglutide as a generic version of Wegovy or Ozempic, and patients should not treat them as interchangeable.
How semaglutide differs from tirzepatide
Semaglutide is a GLP-1 receptor agonist. Tirzepatide, the active ingredient in Mounjaro and Zepbound, activates GIP and GLP-1 receptors, so it is a dual incretin receptor agonist 7, 8. Both drug classes can affect appetite, satiety, gastric emptying, blood sugar, and gastrointestinal side effects, so either option needs clinician review 1, 8.
Chia also offers tirzepatide tablets and injections, with microdosing plans available when clinically appropriate. If you are comparing options, read our guide to buying tirzepatide safely online.
How much does semaglutide cost per month?
Semaglutide cost depends on the product, insurance coverage, dose, pharmacy, visit fees, lab needs, shipping, and follow-up support. Chia’s compounded semaglutide injection plans currently start at $249/month.
What affects the price
- Brand-name versus compounded prescription pathway.
- Whether insurance covers the specific FDA-approved indication on the label.
- Pharmacy price, savings programs, dispensing fees, and supply limits.
- Clinical support, side-effect monitoring, and dose-adjustment visits.
- Shipping, labs, and whether supplies are included.
What Chia lists for compounded semaglutide injection
Chia offers compounded semaglutide injection only. Plans currently start at $249/month, and the product page is the best place to check current pricing. A prescription requires a licensed-provider evaluation and is not guaranteed.
Questions to ask before paying for a semaglutide program
- Will a licensed U.S. clinician review my full medical history before prescribing?
- What pharmacy will prepare or dispense the medication, and is it state-licensed?
- What is included in the monthly price: medication, provider follow-up, supplies, shipping, and messaging?
- How are nausea, vomiting, constipation, reflux, dehydration, or low blood sugar symptoms handled?
- Does the program avoid guaranteed weight-loss claims?
3-min quiz
Considering semaglutide with clinician review?
Chia offers compounded semaglutide injection for eligible patients after an online health questionnaire and licensed-provider review. Plans currently start at $249/month. A prescription is not guaranteed. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
How can you get semaglutide through Chia?
Chia is a 100% online access path for compounded semaglutide injection. You complete a short health questionnaire, then a licensed U.S. provider reviews your information and prescribes only when clinically appropriate.
Online health questionnaire and licensed U.S. provider review
Your online visit asks about your health history, current medications, weight-related goals, prior GLP-1 use, side effects, and safety factors. Our providers use that information to decide whether semaglutide is appropriate or whether another option may fit better.
Compounded semaglutide injection from state-licensed 503A pharmacies
If prescribed, Chia’s semaglutide is compounded in the U.S. by state-licensed 503A compounding pharmacies and shipped to your door. Federal law treats eligible 503A compounded drugs differently from FDA-approved drugs, and FDA notes that compounded drugs are not FDA-approved 4.
Microdosing plans when clinically appropriate
Chia lists microdosing plans for semaglutide when clinically appropriate. We do not give one-size-fits-all dosing instructions in public articles because dosing and dose changes should be guided by a licensed clinician.
Home shipping and patient portal messaging
Patients can message their care team through the patient portal between visits. That follow-up matters because GLP-1 medicines can cause side effects, and FDA labels describe risks that may require treatment changes, symptom review, or urgent care in rare cases 1, 2.
Using Chia’s quiz or DoctorMCP to start
You can start with Chia’s eligibility quiz. For agent-assisted prescription workflows, Chia is also reachable through DoctorMCP at mcp.chia.health, which can help route the access path but does not guarantee eligibility or a prescription.
Who may be eligible for semaglutide treatment?
Eligibility depends on your medical history, current medications, treatment goals, and the clinician’s judgment. A person may be a fit for one semaglutide pathway, a different GLP-1 option, lifestyle-first care, or no medication.
FDA-approved semaglutide products have specific labeled uses. Wegovy is labeled for chronic weight management in certain people with obesity or overweight and at least one weight-related condition, while Ozempic and Rybelsus are labeled for adults with type 2 diabetes 1, 2, 3.
A clinician may recommend against semaglutide if the safety profile does not fit your history. Labels warn against use in people with a personal or family history of medullary thyroid carcinoma or MEN2, and they describe additional warnings around pancreatitis, gallbladder disease, kidney injury, severe gastrointestinal disease, diabetic retinopathy complications, and hypoglycemia when combined with certain diabetes medicines 1, 2, 3.
Sometimes another option may be discussed. For example, Chia offers Weight + Energy, which pairs NAD+ injection with a choice of GLP-1 when clinically appropriate, and Weight + Muscle, which pairs sermorelin injection with a choice of GLP-1 when clinically appropriate. These protocols still require provider review and a prescription where required.
How do brand-name and compounded semaglutide compare?
Brand-name and compounded semaglutide can both involve prescription semaglutide, but they are not the same product. FDA-approved drugs have FDA-reviewed labeling, manufacturing, safety, and effectiveness data; compounded medications are patient-specific preparations that are not FDA-approved 4.
| Option | What it is | Common use on FDA label | Form | Key access notes |
|---|---|---|---|---|
| Wegovy | Brand-name semaglutide, GLP-1 receptor agonist | Chronic weight management in certain patients; certain cardiovascular risk reduction uses | Injection | Prescription required; FDA-approved product with labeled warnings and side effects 1 |
| Ozempic | Brand-name semaglutide, GLP-1 receptor agonist | Type 2 diabetes; certain cardiovascular and kidney-related risk uses in that population | Injection | Prescription required; not labeled as a weight-loss drug 2 |
| Rybelsus | Brand-name oral semaglutide, GLP-1 receptor agonist | Type 2 diabetes | Tablet | Prescription required; oral administration has specific label directions that should be reviewed by a clinician 3 |
| Compounded semaglutide | Patient-specific compounded medication | Not FDA-approved | Varies by provider and pharmacy; Chia offers injection only | Prescription required; should come from a state-licensed 503A pharmacy when compounded 4 |
Cost, access, and formulation may matter, but they should not replace safety review. FDA has warned patients about unapproved GLP-1 products sold online, dosing errors, and products that may not contain the same active ingredient as approved semaglutide medicines 5.
What safety questions should you ask before buying semaglutide online?
Buying semaglutide online can be legitimate when there is a licensed clinician, a valid prescription, and a licensed pharmacy. Be careful with any site that skips medical review, sells research chemicals, or promises guaranteed weight loss.
- Is a licensed clinician reviewing your health history before any prescription?
- Is the dispensing or compounding pharmacy state-licensed?
- Will someone monitor side effects such as nausea, vomiting, constipation, diarrhea, reflux, dehydration symptoms, or low blood sugar symptoms?
- Does the program explain contraindications and warnings from semaglutide labeling, including thyroid C-cell tumor warning, pancreatitis warning, gallbladder issues, kidney injury, and hypoglycemia risk with certain diabetes medicines 1, 2?
- Does the site avoid guaranteed outcome claims? In trials, semaglutide’s active ingredient produced average results across groups, but individual results varied and adverse events occurred 6, 9.
- Does the program clearly distinguish FDA-approved products from compounded medications?
If a website says you can buy semaglutide with no prescription, no health questions, or no follow-up, that is a red flag. For more detail, see our patient guide on where to buy weight-loss injections online.
What is the safest next step if you are considering semaglutide?
The safest next step is a licensed-provider evaluation before treatment. Bring your medication list, health history, prior weight-loss medication experience, diabetes history, pregnancy plans, and questions about cost and follow-up.
- 1Write down your current prescriptions, over-the-counter medicines, supplements, and allergies.
- 2List any history of pancreatitis, gallbladder disease, kidney problems, severe gastrointestinal symptoms, diabetic eye disease, thyroid cancer, MEN2, or low blood sugar episodes.
- 3Compare total monthly cost, not just the drug price.
- 4Ask how side effects and dose changes are handled.
- 5Use a licensed access path, such as Chia’s online eligibility quiz, before starting treatment.
3-min quiz
Start with a licensed-provider evaluation
If you want to explore compounded semaglutide injection through Chia, start with the online quiz. Our providers review your information and prescribe only when clinically appropriate. Chia plans for compounded semaglutide injection currently start at $249/month; eligibility and prescriptions are never guaranteed.
Frequently asked questions about buying semaglutide
Yes. Semaglutide is a prescription medication in the U.S. A licensed clinician should review your medical history, current medications, goals, side-effect risks, and contraindications before prescribing.
Sometimes. Price depends on brand versus compounded access, insurance, pharmacy pricing, visit fees, supplies, shipping, and follow-up. Chia offers compounded semaglutide injection plans currently starting at $249/month for eligible patients.
Wegovy cost varies by insurance, pharmacy, dose, savings programs, and current manufacturer terms. Check your plan, pharmacy, and the manufacturer’s current pricing resources before paying.
There is no single U.S. price. Brand-name injections and compounded injections can have different costs. Chia’s compounded semaglutide injection plans currently start at $249/month, with provider review required.
Wegovy and Ozempic are FDA-approved brand-name semaglutide products with FDA-reviewed labeling. Compounded semaglutide is prepared for an individual prescription by a compounding pharmacy and is not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality.
Yes, some legitimate telehealth and pharmacy pathways can ship semaglutide to your home after clinician review and a valid prescription. At Chia, prescribed compounded semaglutide injection is shipped from state-licensed U.S. 503A pharmacies.
No. Chia never guarantees a prescription. A licensed U.S. provider reviews your information and prescribes only when clinically appropriate.
Chia is reachable through DoctorMCP at mcp.chia.health for agent-assisted prescription workflows. That can help start the access path, but it does not guarantee eligibility, treatment, or a prescription.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2024.
- 2.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
- 3.U.S. Food and Drug Administration. Rybelsus (semaglutide) tablets prescribing information. 2024.
- 4.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2024.
- 5.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2025.
- 6.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- 7.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2024.
- 8.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
- 9.Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults with Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
